NR567 ADVANCED PHARMACOLOGY FOR THE AGACNP FINAL
EXAM QUESTIONS AND CORRECT ANSWERS (VERIFIED ANSWERS)
PLUS RATIONALES 2026 Q&A | LATEST EXAM UPDATE 2026/2027 |
INSTANT DOWNLOAD PDF
,CORE DOMAINS
Pharmacokinetics and Pharmacodynamics in Acute Care
Pharmacogenomics and Precision Prescribing
Cardiovascular Pharmacology and Hemodynamics
Respiratory and Critical Care Pharmacology
Endocrine and Metabolic Emergencies
Neurological and Psychopharmacology in Acute Care
Anti-infective Therapy and Antimicrobial Stewardship
Gastrointestinal and Renal Pharmacology
Pharmacology of Sedation, Analgesia, and Neuromuscular Blockade
Toxicology, Antidotes, and Adverse Drug Reactions
Regulatory, Ethical, and Prescriptive Authority Considerations
INTRODUCTION
The NR567 Final Examination assesses the advanced practice nursing student's
mastery of pharmacologic principles essential for the Adult-Gerontology Acute
Care Nurse Practitioner (AGACNP). It evaluates pharmacokinetic and
pharmacodynamic reasoning, evidence-based prescribing in critical care, and
management of complex medication regimens across acute and emergent
conditions. The examination employs multiple-choice and scenario-based
questions to simulate real-world acute care decision-making. Emphasis is placed
on hemodynamic support, antimicrobial stewardship, sedation and analgesia,
toxicology, and safe prescribing in high-acuity populations. This assessment
prepares candidates for autonomous pharmacologic management in acute care
settings and certification success.
SECTION ONE: QUESTIONS 1–100
1. A 68-year-old male with septic shock is initiated on norepinephrine. Which
receptor activity is primarily responsible for the drug's vasoconstrictive
effect?
,A. Beta-1 agonism
B. Alpha-1 agonism
C. Beta-2 agonism
D. Dopamine agonism
B. Alpha-1 agonism
RATIONALE: Norepinephrine is a potent alpha-1 agonist, causing peripheral
vasoconstriction and increased systemic vascular resistance. This is the primary
mechanism for elevating mean arterial pressure in septic shock. Its beta-1 activity
also provides inotropic support, but vasoconstriction is mediated by alpha-1
receptors.
2. A patient in acute decompensated heart failure is prescribed nesiritide.
What is the mechanism of action of this agent?
A. Recombinant B-type natriuretic peptide causing vasodilation and diuresis
B. Phosphodiesterase-3 inhibitor increasing cAMP
C. Calcium sensitizer enhancing myocardial contractility
D. Alpha-2 agonist reducing sympathetic outflow
A. Recombinant B-type natriuretic peptide causing vasodilation and diuresis
RATIONALE: Nesiritide is a recombinant form of human B-type natriuretic
peptide (BNP). It binds to natriuretic peptide receptors, causing smooth muscle
relaxation, vasodilation, and increased renal excretion of sodium and water. It
reduces preload and afterload without direct inotropic effects.
3. Which of the following medications is a selective beta-1 antagonist
commonly used for rate control in atrial fibrillation?
A. Carvedilol
B. Esmolol
C. Labetalol
D. Propranolol
, B. Esmolol
RATIONALE: Esmolol is a short-acting, selective beta-1 antagonist with a
rapid onset and short half-life, making it ideal for acute rate control in atrial
fibrillation. Carvedilol and labetalol have alpha-blocking properties as well.
Propranolol is non-selective and less suitable for acute titration.
4. A patient with acute respiratory distress syndrome (ARDS) is receiving
cisatracurium for neuromuscular blockade. Which monitoring parameter is
essential to assess adequate paralysis?
A. Train-of-four stimulation
B. Arterial blood gas
C. Central venous pressure
D. Serum lactate
A. Train-of-four stimulation
RATIONALE: Train-of-four (TOF) stimulation assesses the degree of
neuromuscular blockade by measuring the response of the adductor pollicis muscle
to four supramaximal stimuli. Maintaining 1–2 twitches out of 4 is the goal for
adequate paralysis while allowing for periodic assessment and preventing
prolonged blockade.
5. A patient with opioid-induced respiratory depression is administered
naloxone. Which finding indicates a therapeutic response?
A. Increased respiratory rate and improved consciousness
B. Decreased heart rate
C. Increased blood pressure
D. Pupillary dilation
A. Increased respiratory rate and improved consciousness
RATIONALE: Naloxone reverses opioid-induced respiratory depression,
sedation, and hypotension. A therapeutic response is characterized by increased